Lead sponsor
Bellus Health Inc. - a GSK company
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
0
Ongoing
2,530
Total enrollment
135
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 3
3
Trials by status
Unknown
3
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's DiseaseAlzheimer's diseasePh 3Unknown950
European Study of 3APS in Mild to Moderate Alzheimer's Disease PatientsAlzheimer's diseasePh 3Unknown930
Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's DiseaseStudy partner/caregiver requiredPh 3Unknown650